iSpecimen amends Series C Preferred Stock terms to add anti-dilution adjustment for reverse splits

iSpecimen Inc.

On Jan 16, 2026, iSpecimen filed amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock.
Amendment adjusts Conversion Price and Floor Price proportionately on any reverse stock split or share combination.
Approved by holders of majority of outstanding Series C Preferred Stock per Section 23 of original designation.
No other changes to terms, preferences, or privileges of Series C Preferred Stock.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

iSpecimen Inc.: Filed an Amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock that adjusts Conversion Price and Floor Price proportionately upon reverse stock splits or similar transactions (effective 2026-01-16).

Change: charter amendment
Effective: 2026-01-16

Exact text from the filing

On January 16, 2026, the Company filed an Amended Certificate of Designations, Preferences and Rights of the Series C Convertible Non-Voting Preferred Stock (the “ Amended Certificate of Designation ”) with the Secretary of State of the State of Delaware.

View on SEC.gov

Browse all governance changes →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-005138

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.